GeneDx Holdings (WGS) Cash from Investing Activities (2020 - 2026)

GeneDx Holdings has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$17.3 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 83.41% year-over-year to -$17.3 million; the TTM figure through Mar 2026 stood at -$69.4 million (down 71.77% YoY), while the FY2025 annual figure was -$61.5 million, down 104.16% from the prior year.
• Cash from Investing Activities retreated to -$17.3 million in Q1 2026, from -$11.1 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for WGS reached as high as $843000.0 in Q1 2024 and fell as low as -$130.3 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is -$7.8 million (2024), against an average of -$17.3 million.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 2807.77% — and 2024, when it jumped 282.47%.
• A 5-year view of Cash from Investing Activities shows it stood at -$2.8 million in 2022, then slumped by 71.39% to -$4.9 million in 2023, then surged by 89.33% to -$519000.0 in 2024, then sank by 2033.33% to -$11.1 million in 2025, then slumped by 55.84% to -$17.3 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$17.3 million, -$11.1 million, and -$4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.